Antihormone treatment differentially regulates PSA secretion, PSMA expression and (68)Ga–PSMA uptake in LNCaP cells

BACKGROUND: In recent years, a variety of innovative therapeutics for castration-resistant prostate cancer have been developed, including novel anti-androgenic drugs, such as abiraterone or VPC-13566. Therapeutic monitoring of these pharmaceuticals is performed either by measuring PSA levels in seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathy, C. S., Mayr, T., Kürpig, S., Meisenheimer, M., Dolscheid-Pommerich, R. C., Stoffel-Wagner, B., Kristiansen, G., Essler, M., Muders, M. H., Bundschuh, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076114/
https://www.ncbi.nlm.nih.gov/pubmed/33760944
http://dx.doi.org/10.1007/s00432-021-03583-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076114/
https://www.ncbi.nlm.nih.gov/pubmed/33760944
http://dx.doi.org/10.1007/s00432-021-03583-w

Ejemplares similares